ClearanceBrief
510(k) K212289 ยท QCI Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder

NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy System, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy for Mental Health, NeuroStar

ApplicantNeuronetics, Inc., Malvern PA, US
DecisionSubstantially Equivalent, May 6, 2022
ReceivedJul 21, 2021
TypeTraditional
FDA recordOpen on fda.gov

Recalls that name K212289

No recall in the FDA data names this 510(k).

Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.